Celularity- Warrants (16/07/2026) Profit Margin

As of the most recent data (March 2026), CELUW shows a profit margin of -375.77%. That compares with -135.63% in the prior-year period — down 177.1% year over year. That is below the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CELUW's profit margin is now -375.77% (was -135.63%) — a 177.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Celularity- Warrants (16/07/2026) is outperforming or lagging.

The Healthcare sector average profit margin is about 21.34%. Celularity- Warrants (16/07/2026) is at -375.77%, which is lower that average. That is roughly 1861.3% below the sector mean. Use the comparison chart on this page to see how CELUW stacks up against individual peers as well.

That compares with -135.63% in the prior-year period — down 177.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Celularity- Warrants (16/07/2026) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Celularity- Warrants (16/07/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -375.77%) with ownership activity and broader fundamentals.